Embryonal rhabdomyosarcoma of the uterine cervix is an uncommon presentation of the most common soft-tissue sarcoma in the first decades of life. Unlike embryonal rhabdomyosarcoma in other anatomic ...

The rhabdomyosarcoma market is expanding as unmet needs in pediatric and young-adult populations drive increased R&D and clinical activity. Additionally, the launch of emerging therapies such as ...

Adding 6 months of maintenance chemotherapy appears to improve survival for patients with high-risk rhabdomyosarcoma (RMS) and will be the new standard of care in future European clinical trials, ...

Scientists at St. Jude Children's Research Hospital have revealed how the tumor suppressor gene PTEN plays a more important role in pediatric rhabdomyosarcoma than was previously appreciated. The ...

Rhabdomyosarcoma is a type of soft tissue cancer. Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing rhabdomyosarcoma recurrence.

Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. While multimodal therapies have improved outcomes for low- and intermediate-risk ...

PRIMARY rhabdomyosarcoma of the tongue is a rare condition to which no reference is available for a complete pathological description or a sound therapeutic approach. The physician confronted with a ...

Scientists have successfully transformed rhabdomyosarcoma cells into healthy functioning muscle cells. Could this lab breakthrough help bring differentiation therapy to the clinic? If so, a new and ...

Rhabdomyosarcoma is rare soft-tissue tumor that is more prevalent among children. In contrast, rhabdomyosarcomas are extremely rare in adults, with soft-tissue sarcomas making up <1% of malignancies ...

Rhabdomyosarcoma (RMS) is a highly malignant tumor and the most common soft tissue sarcoma in children. In spite of its clinical significance, less is known about genetic susceptibility to this ...

Are you searching for effective medications to treat 'Rhabdomyosarcoma'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...

Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive, First-Line Metastatic Breast Cancer Fifty-seven patients with ...